Epigenetics Regulation of Lung Cancer: Implications for Clinical Doctor

被引:0
|
作者
Rojas Moreno, Adriana Patricia [1 ]
Elias Bruges, Ricardo [2 ,3 ]
Canas Arboleda, Alejandra [4 ,5 ]
Fernando Jaramillo, Luis [4 ,5 ]
机构
[1] Pontificia Univ Javeriana, Inst Genet Humana, Carrera 7 40-62,Edificio 32,2 piso, Bogota, Colombia
[2] Ctr Javeriano Oncol, Bogota, Colombia
[3] Inst Nacl Cancerol, Oncol, Bogota, Colombia
[4] Hosp Univ San Ignacio, Bogota, Colombia
[5] Pontificia Univ Javeriana, Bogota, Colombia
来源
UNIVERSITAS MEDICA | 2016年 / 57卷 / 03期
关键词
epigenetic repression; DNA methylation; histone code; lung neoplasms; chromatin;
D O I
10.11144/Javeriana.umed57-3.recp
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lung cancer is the leading cause of malingnancy death worldwide. This phenomenon occurs when detected in the most advanced stages of the disease (stage III or IV). There are risk factors described in the generation of this cancer such us the consumption of tabacco, inhalation and subsequent accumulation of radon and asbestos in lung tissue, environmental pollution, the presence of genetic alterations, and the presence of epigenetic factors regulating the expression or repression of genes involved in tumor development. Epigenetic regulation mechanisms may get involved in tumor progression. They are DNA methylation, histone covalent modification and the presence of noncoding RNAs. At different stages of tumor progression it described, the involve of epigenetic mechanisms as regulators of processes related to proliferation, epithelial mesenchymal transition, metastasis, apoptosis, and others describes different stages of the tumor progression. This review focuses on describing the role of epigenetics in the progression of the lung tumor and remarks on the importance of enhancing knowledge in this discipline for diagnosis and treatment.
引用
收藏
页码:332 / 347
页数:16
相关论文
共 50 条
  • [11] Lung cancer epigenetics and genetics
    Risch, Angela
    Plass, Christoph
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (01) : 1 - 7
  • [12] Epigenetics in Metastatic Breast Cancer Its Regulation and Implications in Diagnosis, Prognosis and Therapeutics
    Wu, Yuan Seng
    Lee, Zhong Yang
    Chuah, Lay-Hong
    Mai, Chun Wai
    Ngai, Siew Ching
    CURRENT CANCER DRUG TARGETS, 2019, 19 (02) : 82 - 100
  • [13] Clinical Implications of MicroRNAs in Lung Cancer
    Fanini, Francesca
    Vannini, Ivan
    Amadori, Dino
    Fabbri, Muller
    SEMINARS IN ONCOLOGY, 2011, 38 (06) : 776 - 780
  • [14] Epigenetics alternation in lung fibrosis and lung cancer
    Li, Xueren
    Feng, Chunjing
    Peng, Shouchun
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [15] Clinical implications of epigenetics in bone diseases
    Cooper, C.
    BONE, 2011, 48 : S56 - S56
  • [16] Lung cancer - 9: Molecular biology of lung cancer: clinical implications
    Fong, KM
    Sekido, Y
    Gazdar, AF
    Minna, JD
    THORAX, 2003, 58 (10) : 892 - 900
  • [17] Epigenetics: Origins and implications for cancer epidemiology
    Nise, Melissa S.
    Falaturi, Puran
    Erren, Thomas C.
    MEDICAL HYPOTHESES, 2010, 74 (02) : 377 - 382
  • [18] Cancer Epigenetics: Clinical Perspectives
    Ahmad, Aamir
    CURRENT CANCER DRUG TARGETS, 2019, 19 (07) : 513 - 514
  • [19] Cancer epigenetics in clinical practice
    Davalos, Veronica
    Esteller, Manel
    CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (04) : 376 - 424
  • [20] Epigenetics of lung cancer: a translational perspective
    Quintanal-Villalonga, Alvaro
    Molina-Pinelo, Sonia
    CELLULAR ONCOLOGY, 2019, 42 (06) : 739 - 756